Clinicochemical, haematological and histopathological alterations were demonstrated in broiler chickens following repeated oral bolus administration of two different enrofloxacin generic preparations, formulated as 10% oral solutions, given at a dose regimen of 10 mg/Kg body weight for 5 consecutive days. The two tested preparations were Enrol® (Medmac®, Jordan), referred thereafter as ENRO-A; and Syvaquinol® (Syva®, Spain), which referred thereafter as ENRO-B. Eighteen broilers chickens, aging 40 days old, divided equally and randomly into three groups, have been used in the present study. ENRO-A or ENRO-B was given via intra-crop route of administration at the above-mentioned dose regimen to birds of the 2nd and the 3rd groups, respectively; where those of the 1st group were given water instead and kept as control. Blood samples were collected from all birds via the wing and metatarsal veins on the 5th day for clinicochemical and haematological examinations. Birds were then humanely sacrificed and liver, kidneys and heart were dissected out for histopathological examination. Results revealed that ENRO-A induced a significant (p |
